Portal:CPTAC/Hallmarks

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(New page: {| style="margin: 10px; background-color:#eaf2ee" |width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{#pwImage:Pathway:WP2868|250px||TCA ...)
Current revision (18:59, 5 October 2017) (view source)
(added Therapeutics category)
 
(8 intermediate revisions not shown.)
Line 1: Line 1:
-
{| style="margin: 10px; background-color:#eaf2ee"
+
{| style="width:100%; margin: 10px; background-color:#eaf2ee"
-
|width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}}
+
|width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}}
-
|width=100px; style="text-align:center;"|'''Evading growth suppressors'''{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}}
-
|width=100px; style="text-align:center;"|'''Activating invasion and metastasis''' {{#pwImage:Pathway:WP2828|250px||Bladder Cancer}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Invasion|<big><u><b>Activating invasion and metastasis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Invasion}}
-
|width=100px; style="text-align:center;"|'''Enabling replicative immortality''' {{#pwImage:Pathway:WP581|250px||EPO Receptor Signaling}}
+
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP673|250px||ErbB Signaling Pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/immortality|<big><u><b>Enabling replicative immortality</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/immortality}}
-
|width=100px|{{#pwImage:Pathway:WP585|250px||Interferon type I signaling pathways}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Angiogenesis|<big><u><b>Inducing angiogenesis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Angiogenesis}}
-
|width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Resisting|<big><u><b>Resisting cell death</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Resisting}}
-
|width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}}
+
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Deregulating|<big><u><b>Deregulating cellular energetics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Deregulating}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}}
 +
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}}
|}
|}

Current revision

Sustaining proliferative signaling

Hippo-Merlin signaling dysregulation (Homo sapiens)

Image does not exist
Hippo-Merlin signaling dysregulation
Evading growth suppressors

G1 to S cell cycle control (Homo sapiens)

Image does not exist
G1 to S cell cycle control
Activating invasion and metastasis

TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition (Homo sapiens)

Image does not exist
TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition
Enabling replicative immortality

Wnt signaling, NetPath (Homo sapiens)

Image does not exist
Wnt signaling, NetPath
Inducing angiogenesis

PDGF pathway (Homo sapiens)

Image does not exist
PDGF pathway
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

TCA cycle nutrient use and invasiveness of ovarian cancer (Homo sapiens)

Image does not exist
TCA cycle nutrient use and invasiveness of ovarian cancer
Genome instability and mutation

ATR signaling (Homo sapiens)

Image does not exist
ATR signaling
Tumor promoting inflammation

IL6 signaling (Homo sapiens)

Image does not exist
IL6 signaling
Avoiding immune destruction

Type II interferon signaling (Homo sapiens)

Image does not exist
Type II interferon signaling
Therapeutics

NRF2-ARE regulation (Homo sapiens)

Image does not exist
NRF2-ARE regulation
Retrieved from "https://oldclassic.wikipathways.org/index.php/Portal:CPTAC/Hallmarks"
Personal tools